Decreased survival in diabetic patients with heart failure due to systolic dysfunction

Masoor Kamalesh, Usha Subramanian, Stephen Sawada, George Eckert, M'Hamed Temkit, William Tierney

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Prognosis of patients with heart failure (HF) has improved in recent years due to advances in therapy. Whether this is also true for diabetic subjects with HF in clinical practice has not been studied in a prospective manner. Methods: All patients with HF and left ventricular systolic dysfunction attending the outpatient clinic at our Veteran's Hospital between October 1999 and November 2000 were enrolled in our study and followed prospectively. Electronic medical records were accessed for data on comorbid conditions, medications, echocardiogram results and mortality information. Mean follow-up was 2.7 years. Results: Of 495 patients with HF due to systolic dysfunction enrolled in the study, 293 (59%) had diabetes. Prevalence of hypertension, diuretic use and angiotensin converting enzyme inhibitor use was higher among diabetics. Beta-blocker usage was equal and high in both groups (60%). On follow-up, 109/273 (37%) patients in the diabetic group died, compared with 49/202 (24%) in the non-diabetic group. Independent predictors of death were diabetes (p < 0.005, OR = 1.73), age at enrollment (p < 0.0001, OR = 1.06), serum creatinine (p < 0.01, OR = 1.44) and diuretic use (p = 0.038, OR = 1.85). Beta-blocker use was associated with a decreased risk of death on univariate analysis only. Conclusions: Our results show that diabetic patients with HF continue to have higher mortality than non-diabetic patients with HF despite advances in therapy.

Original languageEnglish
Pages (from-to)404-408
Number of pages5
JournalEuropean Journal of Heart Failure
Volume8
Issue number4
DOIs
StatePublished - Jun 2006

Fingerprint

Heart Failure
Survival
Diuretics
Veterans Hospitals
Mortality
Electronic Health Records
Left Ventricular Dysfunction
Ambulatory Care Facilities
Angiotensin-Converting Enzyme Inhibitors
Creatinine
Hypertension
Therapeutics
Serum

Keywords

  • Diabetes
  • Heart failure
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Decreased survival in diabetic patients with heart failure due to systolic dysfunction. / Kamalesh, Masoor; Subramanian, Usha; Sawada, Stephen; Eckert, George; Temkit, M'Hamed; Tierney, William.

In: European Journal of Heart Failure, Vol. 8, No. 4, 06.2006, p. 404-408.

Research output: Contribution to journalArticle

Kamalesh, Masoor ; Subramanian, Usha ; Sawada, Stephen ; Eckert, George ; Temkit, M'Hamed ; Tierney, William. / Decreased survival in diabetic patients with heart failure due to systolic dysfunction. In: European Journal of Heart Failure. 2006 ; Vol. 8, No. 4. pp. 404-408.
@article{419462baf3d24a65ba09692837e402e1,
title = "Decreased survival in diabetic patients with heart failure due to systolic dysfunction",
abstract = "Background: Prognosis of patients with heart failure (HF) has improved in recent years due to advances in therapy. Whether this is also true for diabetic subjects with HF in clinical practice has not been studied in a prospective manner. Methods: All patients with HF and left ventricular systolic dysfunction attending the outpatient clinic at our Veteran's Hospital between October 1999 and November 2000 were enrolled in our study and followed prospectively. Electronic medical records were accessed for data on comorbid conditions, medications, echocardiogram results and mortality information. Mean follow-up was 2.7 years. Results: Of 495 patients with HF due to systolic dysfunction enrolled in the study, 293 (59{\%}) had diabetes. Prevalence of hypertension, diuretic use and angiotensin converting enzyme inhibitor use was higher among diabetics. Beta-blocker usage was equal and high in both groups (60{\%}). On follow-up, 109/273 (37{\%}) patients in the diabetic group died, compared with 49/202 (24{\%}) in the non-diabetic group. Independent predictors of death were diabetes (p < 0.005, OR = 1.73), age at enrollment (p < 0.0001, OR = 1.06), serum creatinine (p < 0.01, OR = 1.44) and diuretic use (p = 0.038, OR = 1.85). Beta-blocker use was associated with a decreased risk of death on univariate analysis only. Conclusions: Our results show that diabetic patients with HF continue to have higher mortality than non-diabetic patients with HF despite advances in therapy.",
keywords = "Diabetes, Heart failure, Prognosis",
author = "Masoor Kamalesh and Usha Subramanian and Stephen Sawada and George Eckert and M'Hamed Temkit and William Tierney",
year = "2006",
month = "6",
doi = "10.1016/j.ejheart.2005.10.005",
language = "English",
volume = "8",
pages = "404--408",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Decreased survival in diabetic patients with heart failure due to systolic dysfunction

AU - Kamalesh, Masoor

AU - Subramanian, Usha

AU - Sawada, Stephen

AU - Eckert, George

AU - Temkit, M'Hamed

AU - Tierney, William

PY - 2006/6

Y1 - 2006/6

N2 - Background: Prognosis of patients with heart failure (HF) has improved in recent years due to advances in therapy. Whether this is also true for diabetic subjects with HF in clinical practice has not been studied in a prospective manner. Methods: All patients with HF and left ventricular systolic dysfunction attending the outpatient clinic at our Veteran's Hospital between October 1999 and November 2000 were enrolled in our study and followed prospectively. Electronic medical records were accessed for data on comorbid conditions, medications, echocardiogram results and mortality information. Mean follow-up was 2.7 years. Results: Of 495 patients with HF due to systolic dysfunction enrolled in the study, 293 (59%) had diabetes. Prevalence of hypertension, diuretic use and angiotensin converting enzyme inhibitor use was higher among diabetics. Beta-blocker usage was equal and high in both groups (60%). On follow-up, 109/273 (37%) patients in the diabetic group died, compared with 49/202 (24%) in the non-diabetic group. Independent predictors of death were diabetes (p < 0.005, OR = 1.73), age at enrollment (p < 0.0001, OR = 1.06), serum creatinine (p < 0.01, OR = 1.44) and diuretic use (p = 0.038, OR = 1.85). Beta-blocker use was associated with a decreased risk of death on univariate analysis only. Conclusions: Our results show that diabetic patients with HF continue to have higher mortality than non-diabetic patients with HF despite advances in therapy.

AB - Background: Prognosis of patients with heart failure (HF) has improved in recent years due to advances in therapy. Whether this is also true for diabetic subjects with HF in clinical practice has not been studied in a prospective manner. Methods: All patients with HF and left ventricular systolic dysfunction attending the outpatient clinic at our Veteran's Hospital between October 1999 and November 2000 were enrolled in our study and followed prospectively. Electronic medical records were accessed for data on comorbid conditions, medications, echocardiogram results and mortality information. Mean follow-up was 2.7 years. Results: Of 495 patients with HF due to systolic dysfunction enrolled in the study, 293 (59%) had diabetes. Prevalence of hypertension, diuretic use and angiotensin converting enzyme inhibitor use was higher among diabetics. Beta-blocker usage was equal and high in both groups (60%). On follow-up, 109/273 (37%) patients in the diabetic group died, compared with 49/202 (24%) in the non-diabetic group. Independent predictors of death were diabetes (p < 0.005, OR = 1.73), age at enrollment (p < 0.0001, OR = 1.06), serum creatinine (p < 0.01, OR = 1.44) and diuretic use (p = 0.038, OR = 1.85). Beta-blocker use was associated with a decreased risk of death on univariate analysis only. Conclusions: Our results show that diabetic patients with HF continue to have higher mortality than non-diabetic patients with HF despite advances in therapy.

KW - Diabetes

KW - Heart failure

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=33744797415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744797415&partnerID=8YFLogxK

U2 - 10.1016/j.ejheart.2005.10.005

DO - 10.1016/j.ejheart.2005.10.005

M3 - Article

C2 - 16309953

AN - SCOPUS:33744797415

VL - 8

SP - 404

EP - 408

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 4

ER -